Articles | elsewhere

Linear Capital Wins Multiple Awards at Jazzyear's "China Technology Industry Investment Ranking," Including Best Investment Firm in AI and Big Data

At the end of July, the Chinese tech think tank *Jazzyear* held the 2022 "Jazzyear Gravity X" Tech Industry Investment Summit in Beijing, where it released the "2021-2022 China Tech Industry Investment Rankings." Linear Capital was among the honorees, receiving awards including "Top 20 Best Investment Firms in AI and Big Data" and "Top 20 Best Investment Firms in Enterprise Services."

线性资本·2022年8月1日

On the first day of August, we spoke with 23 investors about "confidence."

And, what are the things that are hard but right, and what are the things that are hard but wrong.

暗涌Waves·2022年8月1日

"Guoguang Shunneng" Raises Eight-Figure Angel Round from Linear Capital and HSG to Build Safe, Efficient Mobile Power Station Products Using New Energy Vehicle Technology

Dedicated to providing users with seamless, "unfelt" wireless charging services.

线性资本·2022年7月29日

Linear News | SynBio Startup "Biosys" Secures Two Funding Rounds in Six Months, Linear Capital Leads Angel Round

"Besheng Bio's" long-term goal is to build a complete biotech ecosystem based on the ArchiCel architecture — in essence, to create the Windows + x86 equivalent for the biotechnology industry.

线性资本·2022年7月26日

Peng Kaiping: Entrepreneurship Is a Long-Distance Race — Physical and Mental Strength Early On, Resilience for the Long Haul | Ronghui Practical Insights

Behind every successful entrepreneur who takes their craft to the highest level lies a shared trait: psychological resilience.

高榕创投·2022年7月26日

Meike Technology, Shouhoubao, and Arctic Data Named 2022 High-Growth Brands and Best Service Providers | Oasis Vitality

**"2022 High-Growth Brands and Best Service Providers Rankings"** . The research and selection process behind these rankings aims to better understand the current state and trajectory of China's consumer industry and industrial digitalization, identify high-growth domestic emerging brands, and uncover outstanding technology companies within China's consumer industry chain.

绿洲资本·2022年7月26日

Biosys Biotechnology Closes Angel Round, Total Funding Exceeds 100 Million Yuan | Oasis Capital

**Biosynth, a synthetic biology company focused on species design and application,** completed two consecutive funding rounds within six months. **The angel round was jointly invested by Oasis Capital, HSG, and Linear Capital;** the seed round was led by HSG Seed Fund, with MiraclePlus and Sky9 Capital participating. MiraclePlus and Sky9 Capital, investors in the seed round, continued to increase their stakes in the company. The cumulative amount raised across both rounds exceeded RMB 100 million. **Dr. Yu Chen, founder and CEO of Biosynth, said:** "Green

绿洲资本·2022年7月26日

Where Are the Next-Generation Consumer Opportunities in 2022? | Li Feng Column

What Will the Next Generation of Consumer Innovations Look Like?

峰瑞资本·2022年7月22日

Buyouts in China: A "Boy Who Cried Wolf" Fable

After so many cycles of euphoria and heartbreak, will Chinese buyouts finally deliver a different ending this time?

暗涌Waves·2022年7月22日

A Conversation with Suji Yan: Rebelling Against Giants, Becoming a Giant

The dragon-slayer, too, wants to become a dragon.

暗涌Waves·2022年7月22日